Breaking News

Thermo Systems Partners with Adents

February 11, 2016

Combines software expertise and implementation know-how to increase safety and security implementation capabilities

Thermo Systems, a full-service automation and information solutions company, has partnered with Adents, a provider of serialization and track-and-trace software solutions, to offer highly advanced and reliable safety and security software implementation options. Thermo Systems will become a supplier of Adents serialization software to its nationwide set of customers.

“Partnering with Adents allows Thermo Systems to offer an effective, comprehensive serialization solution for our customers in regulated industries,” said Steve Ryan, chief strategy officer, Thermo Systems. “This solution’s reliability and rapid implementation will help Thermo Systems customers meet current and pending international track and trace mandates, including FDA compliance per the Drug Supply Chain Security Act (DSCSA).”

Adents’ unit identification and traceability software is designed to be flexible, scalable and deploy quickly. All of which are important factors, according to the company, for achieving compliance, minimizing counterfeiting, brand protection and enriching marketing initiatives.

“Thermo Systems has a national reach and a fully trained team of engineers ready to deploy Adents serialization solutions to help life science companies efficiently and cost-effectively comply with the looming 2017 DSCSA deadline,” said James Cummings, vice president Americas, Adents Americas. “By using our software tools and global track and trace experience, Thermo Systems has increased its safety and security implementation capabilities on behalf of its customers.” 

Related Packaging:

  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks